A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive Disorder

NCT02476058 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: JNJ-42847922
DRUG: Diphenhydramine
DRUG: Placebo

Sponsor

Janssen-Cilag International NV